Daily Cosmetic Research Analysis
Three complementary reviews advance safety science for cosmetics and personal care: (1) environmental and intrinsic plant factors can drive unpredictable accumulation of genotoxic carcinogens in botanicals used in foods, cosmetics, and herbal products; (2) nanoparticles used in industry and nanomedicine can breach blood-organ barriers via shared molecular pathways; and (3) pharmaceuticals and personal care products accumulate in African sediments at ecologically risky levels, underscoring monito
Summary
Three complementary reviews advance safety science for cosmetics and personal care: (1) environmental and intrinsic plant factors can drive unpredictable accumulation of genotoxic carcinogens in botanicals used in foods, cosmetics, and herbal products; (2) nanoparticles used in industry and nanomedicine can breach blood-organ barriers via shared molecular pathways; and (3) pharmaceuticals and personal care products accumulate in African sediments at ecologically risky levels, underscoring monitoring and regulation gaps.
Research Themes
- Cosmetic and personal care product safety
- Nanotoxicology and biological barrier disruption
- Environmental exposure and regulatory surveillance
Selected Articles
1. Environmental and internal drivers of genotoxic carcinogens accumulation in botanicals and their preparations.
This review synthesizes evidence that internal (genetics, phenology, age) and external (water stress, soil nutrients, geography) drivers can substantially alter levels of genotoxic/carcinogenic compounds in botanicals used for food, cosmetics, and herbal products. It emphasizes unpredictability across chemotypes and calls for systematic benchmarking to human safety thresholds to enable exposure risk assessment.
Impact: It directly informs safety evaluation of botanical ingredients in cosmetics by highlighting environmental and developmental sources of variability in genotoxicants. The work frames a roadmap for threshold-based testing and regulatory surveillance.
Clinical Implications: Clinicians and toxicologists should recognize batch-to-batch variability in botanical products and counsel patients accordingly; regulators and manufacturers should implement standardized sourcing, environmental monitoring, and threshold-based testing to mitigate genotoxic risks in cosmetic botanicals.
Key Findings
- Internal (genetics, phenology, age) and external (water stress, soil nutrients, geography) factors strongly alter plant chemical profiles.
- Genotoxic and carcinogenic compounds can vary widely in botanicals used for food, cosmetics, and herbal products.
- Environmental/developmental effects on chemically uniform plants are under-studied, making risk unpredictable.
- The review urges benchmarking plant hazardous compound levels against human safety thresholds to assess exposure risk.
Methodological Strengths
- Comprehensive, cross-domain synthesis spanning food, cosmetics, and herbal applications.
- Integrates internal and external plant determinants with explicit safety threshold considerations.
Limitations
- Narrative synthesis without explicit PRISMA methodology limits reproducibility.
- Limited empirical data on environmental/developmental effects in chemically uniform plants; no quantitative risk modeling.
Future Directions: Develop standardized agronomic and post-harvest controls, perform longitudinal multi-site monitoring, and implement threshold-based regulatory testing frameworks for cosmetic botanicals.
The use of botanicals and herbal products is increasing globally, especially in developed countries, but their active ingredients are often poorly defined and inconsistently regulated. Moreover, the chemical composition of plants is usually influenced by internal factors (such as genetics, phenology, and age) and external influences (such as environmental conditions). These influences can significantly alter chemical profiles, which is critical for plants used in food, cosmetics, and medicine. Growing concern over harmful compounds in these products highlights the variability in their levels. Specifically, some compounds in plants are known to have genotoxic or carcinogenic effects, and their concentrations can vary greatly depending on these factors. This paper reviews how factors like water stress, soil nutrients, geographic location, and plant development affect the presence of hazardous substances in plants. While genetic factors like chemotypes and cultivars are well-studied, less is known about how environmental and developmental conditions affect chemically uniform plants. Overall, the current work emphasizes the unpredictability of these effects and underscores the need for further research to compare the levels of hazardous compounds in plants against established human safety thresholds, to better assess exposure risks in food, cosmetic and herbal products.
2. Unveiling the hidden risks of human exposure to nanomedicine and nanopollutants: Nanoparticle-induced blood barrier disruption and tissue toxicity.
This review consolidates evidence that nanoparticles (e.g., TiO2, ZnO, PAMAM dendrimers, ceria, copper) can traverse blood-organ barriers and induce toxicity via inflammation, oxidative stress, genotoxicity, organelle dysfunction, and tight junction disruption. It urges mechanism-informed design of safer nanomedicines and clearer regulatory guidance, especially for sensitive organs like the brain and eye.
Impact: By mapping cross-barrier toxicity mechanisms, this work informs both cosmetic safety (e.g., nanoparticle sunscreens) and nanomedicine development, enabling risk mitigation at the formulation and regulatory levels.
Clinical Implications: Healthcare professionals should consider barrier penetration risks when advising on nanoparticle-containing products; regulators should mandate mechanism-informed testing for tight junction integrity and oxidative/inflammatory endpoints.
Key Findings
- Nanoparticles such as TiO2, ZnO, PAMAM dendrimers, ceria, and copper can cross blood-organ barriers (brain, testes, placenta/fetus, eye, lung).
- Shared toxicity pathways include inflammation, redox imbalance, genotoxicity, organelle dysfunction, and tight junction disruption.
- Evidence base is stronger for certain nanoparticles (e.g., TiO2, ZnO) than others, highlighting research gaps.
- Calls for safer NP design and clear disposal/use guidelines to protect sensitive organs.
Methodological Strengths
- Cross-organ synthesis linking barrier penetration with mechanistic toxicity pathways.
- Focus on widely used nanoparticles enhances translational relevance for products and policies.
Limitations
- Heterogeneous study designs and endpoints preclude quantitative meta-analysis.
- Predominance of preclinical data; limited human exposure and dose–response quantification.
Future Directions: Standardize barrier integrity assays, develop organ-specific safety margins, and conduct human-relevant exposure studies for nanoparticle-containing products (including sunscreens and eye formulations).
The development of nanoparticles (NPs) has been a result of the expanding applications of nanotechnology, which play crucial roles in diagnostics, treatments, and theranostics within medical sciences. Despite their promising applications in medicine and industry, NPs can cross blood-organ barriers, resulting in structural and functional disruptions in the affected organs. Gaining insight into how NPs interact with biological barriers is crucial for reducing potential threats to human health. This study seeks to clarify the key mechanisms through which NPs cause toxicity and to investigate their harmful effects on organs (including the brain, testes, fetus, eyes, and lungs) after penetrating their respective biological barriers. We reviewed existing reports in this area and found that the toxic effects of nanoparticles such as titanium dioxide, poly(amidoamine) dendrimers, cerium oxide, copper, and zinc oxide on blood barriers have been studied more extensively than other NPs. Our results provide valuable insights into the potentially toxic effects of NPs on blood barriers and highlight key molecular pathways involved, such as inflammation, redox imbalance, genotoxicity, organelle dysfunction, and tight junction dysfunction in this process. We emphasize the urgent need for future research to focus on developing safer and more effective NP-based therapies (particularly for sensitive organs such as the brain and eyes) by extending our understanding of the mechanisms underlying their toxicity. Our findings offer important evidence for researchers, pharmaceutical companies, and regulatory agencies, encouraging them to develop clear guidelines and regulations for the safe use and disposal of nanoparticles in health-related applications.
3. Pharmaceuticals and personal care products in sediments in Africa: Status, ecological risks, extraction and analytical techniques.
Across African sediments, 35 PPCP classes (142 compounds) have been detected, often at concentrations yielding risk quotients ≥1 for benthic organisms. Ultrasonic extraction with SPE and LC-MS/MS dominate workflows, but uneven geographic coverage and inconsistent reporting hinder comparisons and policy action.
Impact: Provides a continental evidence base for environmental monitoring and regulation of PPCPs, including cosmetics-derived contaminants, highlighting analytical best practices and policy gaps.
Clinical Implications: While primarily environmental, these findings support public health messaging on proper disposal of medications and personal care products, and inform risk assessments for water reuse and aquatic food safety.
Key Findings
- Identified 35 PPCP classes comprising 142 compounds in African sediments (2012–2024).
- Ultrasonic extraction with SPE and LC-MS/MS are the most used methods due to sensitivity and broad analyte coverage.
- Concentrations ranged from <LOD to 28,580 μg/kg d.w., with diclofenac most prevalent.
- Risk quotients frequently ≥1, indicating potential ecological risks to benthic organisms.
- Geographical data gaps (Central/Northern Africa) and inconsistent reporting hinder comparisons.
Methodological Strengths
- Continental-scale synthesis with explicit reporting on classes, analytes, and methods.
- Highlights analytical workflows (extraction and LC-MS/MS) that yield high recovery and sensitivity.
Limitations
- Uneven regional coverage with scarce data in Central and Northern Africa.
- Inconsistent reporting formats and limited temporal monitoring preclude robust trend analyses.
Future Directions: Establish harmonized reporting templates, expand monitoring to data-scarce regions, and integrate ecological RQs with human health risk frameworks for water reuse policies.
This review synthesized literature (2012-2024) about the occurrence of pharmaceuticals and personal care products (PPCPs) in sediments from waterbodies in Africa while highlighting the sources and analytical techniques used. A total of 35 PPCP classes constituting 142 compounds were identified. Eastern Africa reported 21 classes with 60 compounds, Western Africa 17 classes with 69 compounds, Southern Africa 18 classes with 19 compounds, and Northern Africa 1 class with 19 compounds. Publications were scarce in Central and Northern Africa, with most studies reported in Western Africa. Ultrasonic extraction coupled with Solid Phase Extraction (SPE) was the most frequently used sample preparation technique due to its efficiency, cost-effectiveness, simplicity, high recovery rates and ability to extract a wide range of PPCPs. The most frequently used analytical technique was LC-MS/MS due to its superior sensitivity, selectivity, and ability to detect PPCPs at trace levels. The concentration of PPCPs in sediments from waterbodies in Africa ranged from <LOD to 28,580 μg/kg dry weight (d.w). Diclofenac was the most predominant PPCP in Africa. In general, the risk quotient (RQ) values were ≥1 suggesting potential ecological risks to benthic and sediment dwelling organisms. Inconsistent reporting formats and limited temporal monitoring data in Central and Northern Africa hindered inter-continental and inter-regional comparisons. African governments should prioritize research and allocate research funds, invest in analytical infrastructure, strengthen policy and regulatory frameworks, and promote public awareness in the proper disposal and management of waste to mitigate the ecological risks associated with PPCP contamination.